[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367305-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367305-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","effects-of-pharmacological-dose-of-vitamin-c-on-mda-mb-231-cells","Effects of Pharmacological Dose of Vitamin C on MDA-MB-231 Cells","","Study evaluates therapeutic effects of pharmacological (high) dose vitamin C (VC) on triple-negative breast cancer (TNBC) using MDA-MB-231 cells as a model. VC effects are also tested on MCF7, HEK 293, and CCL205 cells. Experiments with MTT, Hoechst and nuclear-ID staining, Rhodamine 123 staining, and Western blot assess cell-killing activity and apoptosis. Results show increased Apaf-1 and caspases, reduced MMP-2/MMP-9, altered cell-cycle protein expression, and enhanced p53/p21. Conclusions support VC as a promising anti-cancer agent that promotes apoptosis and inhibits metastasis in TNBC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/effects-of-pharmacological-dose-of-vitamin-c-on-mda-mb-231-cells/367305/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/effects-of-pharmacological-dose-of-vitamin-c-on-mda-mb-231-cells/367305.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary aim of the study?","Question",{"text":63,"@type":64},"To evaluate whether pharmacological (high-dose) vitamin C has therapeutic anti-cancer effects on TNBC, using MDA-MB-231 cells as the model.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were VC effects on cells investigated?",{"text":68,"@type":64},"Using assays including MTT, Hoechst 33342 staining, nuclear-ID red/green staining, Rhodamine 123 staining, and Western blot analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"What key molecular and functional changes did VC produce?",{"text":72,"@type":64},"VC increased apoptotic markers including Apaf-1 and caspases-7, -8, and -9, inhibited MMP-2 and MMP-9, reduced cell-cycle protein expression, and enhanced tumor suppressor proteins p53 and p21.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367305,1790786310,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":104,"preview_page_count":33,"preview_urls":145},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Article  \nEffects of Pharmacological Dose of Vitamin C on MDA-MB-231 Cells  \nLunawati Lo Bennett  \nAcademic Editor: Stephen Riordan  \nReceived: 4 February 2025  \nRevised: 17 February 2025  \nAccepted: 24 February 2025  \nPublished: 5 March 2025  \nCitation: Bennett, L.L. Effects of Pharmacological Dose of Vitamin C on MDA-MB-231 Cells. Biomedicines 2025, 13, 640. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biomedicines13030640  \nCopyright: © 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nCollege of Pharmacy, Union University, Jackson, TN 38305, USA; [llbennett@uu.edu](llbennett@uu.edu); Tel.: +1-731-661-5921  \nAbstract: Background/Objectives: In 2022, approximately 2.3 million women were diagnosed with breast cancer worldwide, resulting in 670,000 deaths, which accounted for 6.9% of all cancer-related deaths. In the United States, 1 in 8 women will be diagnosed with breast cancer during their lifetime. It was estimated that 2024 would identify about 310,720 women and 2800 men diagnosed with invasive breast cancer. The future global burden of breast cancer is projected to rise to over 3 million new cases and 1 million deaths by 2040 . Approximately 20% of breast cancer diagnoses are triple-negative breast cancer (TNBC), a typeof cancer that lacks receptors for estrogen (ER-negative), progesterone (PR-negative), and human epidermal growth factor receptor 2 (HER2/neu-negative) . Consequently, TNBC does not respond to hormonal or targeted therapies, making it challenging to treat due to its rapid growth, metastasis, and high recurrence rate within the first three years of therapy. Alternative chemotherapies are needed to address this problem. A pharmacological dose of vitamin C (high-dose VC) has been identified as a potential treatment for some cancer cells. The present study aimed to evaluate whether VC has a therapeutic effect on TNBC, using MDA-MB-231 cells as the model. Additionally, VC’s effects were trialed on other cancer cells such as MCF7 and on non-cancerous kidney HEK 293 and lung CCL205 cells. Methods: The MTT assay, Hoechst 33342 staining, nuclear-ID red/green staining, Rhodamine 123 staining, and Western blot analysis were employed to test the hypothesis that apharmacological dose of VC can kill TNBC cells. Results: The upregulation of Apaf-1 and caspases-7, -8, and-9, the inhibition of matrix metalloproteinases (MMP-2 and MMP-9), a reduction in cell cycle protein expression, and the enhancement of tumor suppressor proteins such as p53 and p21 indicate that a pharmacological dose of VC has promising anti-cancer properties in the treatment of breast cancers. Conclusions: Pharmacological dose of VC exerts significant anti-cancer effects in MDA-MB-231 cells by promoting apoptosis, inhibiting metastasis, disrupting cell cycle progression, and enhancing tumor suppressor activity.  \nKeywords: triple-negative breast cancer; vitamin C; caspases; MDA-MB-231; pharmacological dose; MCF7 cells; HEK293 cells; CCL205 cells  \n1. Introduction  \nBreast cancer remains one of the most prevalent and concerning diseases affecting women worldwide. Approximately 2.3 million women have been diagnosed with breast cancer worldwide, with 670,000 deaths, accounting for 6.9% of all cancer-related deaths. In the United States, 1 in 8 women will be diagnosed with breast cancer during their lifetime. It was estimated that, in 2024, 310,720 women and 2800 men would be diagnosed with invasive breast cancer [1–3] . Due to its complex nature and significant impact on public health, extensive research efforts are dedicated to understanding, treating, and ultimately eradicating this disease. Breast cancer consists of various subtypes, one of which","cbCaimOstbXKIaQQ","https://ap.wps.com/l/cbCaimOstbXKIaQQ","pdf",21294355,"English","# Abstract\n# Introduction\n## Breast cancer burden and subtypes\n## Challenges of TNBC\n## Current limitations of treatment\n## Rationale for vitamin C (VC)\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is the primary aim of the study?\",\"answer\":\"To evaluate whether pharmacological (high-dose) vitamin C has therapeutic anti-cancer effects on TNBC, using MDA-MB-231 cells as the model.\"},{\"question\":\"How were VC effects on cells investigated?\",\"answer\":\"Using assays including MTT, Hoechst 33342 staining, nuclear-ID red/green staining, Rhodamine 123 staining, and Western blot analysis.\"},{\"question\":\"What key molecular and functional changes did VC produce?\",\"answer\":\"VC increased apoptotic markers including Apaf-1 and caspases-7, -8, and -9, inhibited MMP-2 and MMP-9, reduced cell-cycle protein expression, and enhanced tumor suppressor proteins p53 and p21.\"}]","Effects of Pharmacological Dose of Vitamin C on MDA-MB-231 Cells | PDF",1790170172,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/250df693db677abd9a5702a25cc21edd.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3dd84c978be508b57ce4e6798fc5888.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55a0433ae875074f1e497decb2362eea.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4d59a1a27bd8eab4d7bf841cff8143a.webp",980,1385]